Rock Springs Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-294,100
Closed -$15M 102
2024
Q4
$15M Buy
294,100
+4,700
+2% +$240K 0.57% 53
2024
Q3
$14.8M Hold
289,400
0.48% 57
2024
Q2
$13M Hold
289,400
0.39% 61
2024
Q1
$13.5M Buy
+289,400
New +$13.5M 0.34% 70